Stem cell-derived extracellular vesicles as senotherapeutics.

Area of Science:

• Gerontology
• Cell Biology
• Regenerative Medicine

Background:

• Cellular senescence (CS) is a key aging hallmark contributing to age-related diseases.
• Accumulated senescent cells create a pro-inflammatory, pro-cancerogenic environment.
• Extracellular vesicles (EVs) mediate cell-cell communication and are explored as senotherapeutics.

Purpose of the Study:

• To review recent studies on the impact of EVs on cellular senescence.
• To discuss the mechanisms behind the senotherapeutic effects of EVs.
• To evaluate the potential of stem cell-derived EVs as a novel therapy.

Main Methods:

• Literature review of studies investigating EVs and cellular senescence.
• Analysis of EVs derived from various stem cells (MSCs, ESCs, iPSCs) and non-stem cells.
• Discussion of proposed mechanisms for EV senotherapeutic effects.

Main Results:

• Stem cell-derived EVs (from pluripotent and multipotent sources) effectively reduce the cellular senescence phenotype in vitro and in vivo.
• EV effects are suggested to be senomorphic, modifying senescent cells rather than eliminating them.
• EVs demonstrate cross-species efficacy with no observed immunogenic responses.

Conclusions:

• Stem cell-derived EVs are promising candidates for senotherapeutics.
• EVs offer a potential cell-free therapeutic strategy for age-related conditions.
• Feasible human applications for stem cell-derived EVs in treating senescence are anticipated.